135 related articles for article (PubMed ID: 8343277)
21. New semisynthetic vinca alkaloids: chemical, biochemical and cellular studies.
Orosz F; Comin B; Raïs B; Puigjaner J; Kovács J; Tárkányi G; Acs T; Keve T; Cascante M; Ovádi J
Br J Cancer; 1999 Mar; 79(9-10):1356-65. PubMed ID: 10188876
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and SAR of vinca alkaloid analogues.
Voss ME; Ralph JM; Xie D; Manning DD; Chen X; Frank AJ; Leyhane AJ; Liu L; Stevens JM; Budde C; Surman MD; Friedrich T; Peace D; Scott IL; Wolf M; Johnson R
Bioorg Med Chem Lett; 2009 Feb; 19(4):1245-9. PubMed ID: 19147348
[TBL] [Abstract][Full Text] [Related]
23. Comparative effects of vindesine, vinblastine, and vincristine on mitotic arrest and hormonal response of L1210 leukemia cells.
Howard SM; Theologides A; Sheppard JR
Cancer Res; 1980 Aug; 40(8 Pt 1):2695-700. PubMed ID: 6248211
[TBL] [Abstract][Full Text] [Related]
24. Determinants of intrinsic sensitivity to Vinca alkaloids in xenografts of pediatric rhabdomyosarcomas.
Houghton JA; Williams LG; Torrance PM; Houghton PJ
Cancer Res; 1984 Feb; 44(2):582-90. PubMed ID: 6692363
[TBL] [Abstract][Full Text] [Related]
25. Pre-clinical studies of a novel anti-mitotic agent, amphethinile.
McGown AT; Ewen C; Smith DB; Fox BW
Br J Cancer; 1988 Feb; 57(2):157-9. PubMed ID: 3358906
[TBL] [Abstract][Full Text] [Related]
26. ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.
Davis PD; Dougherty GJ; Blakey DC; Galbraith SM; Tozer GM; Holder AL; Naylor MA; Nolan J; Stratford MR; Chaplin DJ; Hill SA
Cancer Res; 2002 Dec; 62(24):7247-53. PubMed ID: 12499266
[TBL] [Abstract][Full Text] [Related]
27. Effects on tumour microcirculation in mice of misonidazole and tumour necrosis factor plus hyperthermia.
Fujimoto S; Kobayashi K; Takahashi M; Konno C; Kokubun M; Ohta M; Shrestha RD; Kiuchi S
Br J Cancer; 1992 Jan; 65(1):33-6. PubMed ID: 1733439
[TBL] [Abstract][Full Text] [Related]
28. The in vitro and in vivo effects of vinca alkaloids on the noradrenergic innervation of the vas deferens.
Gardiner SM; Tomlinson DR; Bennett T
Med Biol; 1976 Jun; 54(3):193-202. PubMed ID: 945856
[TBL] [Abstract][Full Text] [Related]
29. Increased plasma serotonin following treatment with flavone-8-acetic acid, 5,6-dimethylxanthenone-4-acetic acid, vinblastine, and colchicine: relation to vascular effects.
Baguley BC; Zhuang L; Kestell P
Oncol Res; 1997; 9(2):55-60. PubMed ID: 9167186
[TBL] [Abstract][Full Text] [Related]
30. Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat.
Greig NH; Soncrant TT; Shetty HU; Momma S; Smith QR; Rapoport SI
Cancer Chemother Pharmacol; 1990; 26(4):263-8. PubMed ID: 2369790
[TBL] [Abstract][Full Text] [Related]
31. Differential cellular retention of vincristine and vinblastine by cultured human promyelocytic leukemia HL-60/Cl cells: the basis of differential toxicity.
Ferguson PJ; Cass CE
Cancer Res; 1985 Nov; 45(11 Pt 1):5480-8. PubMed ID: 3863705
[TBL] [Abstract][Full Text] [Related]
32. Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on axonal fibrillar organelles in vitro.
Donoso JA; Green LS; Heller-Bettinger IE; Samson FE
Cancer Res; 1977 May; 37(5):1401-7. PubMed ID: 558047
[TBL] [Abstract][Full Text] [Related]
33. Use of snail neurons in developing quantitative ultrastructural parameters for neurotoxic side effects of Vinca antitumor agents.
Müller LJ; Moorer-van Delft CM; Zijl R; Roubos EW
Cancer Res; 1990 Mar; 50(6):1924-8. PubMed ID: 2407348
[TBL] [Abstract][Full Text] [Related]
34. Combination of gamma-radiation antagonizes the cytotoxic effects of vincristine and vinblastine on both mitotic arrest and apoptosis.
Sui M; Fan W
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1151-8. PubMed ID: 15752896
[TBL] [Abstract][Full Text] [Related]
35. Biodegradation of the antineoplastics vindesine, vincristine, and vinblastine and their toxicity against bacteria in the aquatic environment.
Al-Ahmad A; Kümmerer K
Cancer Detect Prev; 2001; 25(1):102-7. PubMed ID: 11270417
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxicity of vinblastine and vincristine to pancreatic acinar cells.
Nevalainen TJ
Virchows Arch B Cell Pathol; 1975; 18(2):119-27. PubMed ID: 807028
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of mitomycin-C cytotoxicity by combination with flavone acetic acid in a murine tumour.
Parkins CS; Denekamp J; Chaplin DJ
Anticancer Res; 1993; 13(5A):1437-42. PubMed ID: 8239516
[TBL] [Abstract][Full Text] [Related]
38. A comparison of the antifertility effects of alkylating agents and vinca alkaloids in male rats.
Cooke RA; Nikles A; Roeser HP
Br J Pharmacol; 1978 Aug; 63(4):677-81. PubMed ID: 687878
[TBL] [Abstract][Full Text] [Related]
39. Reduced tumor oxygenation by treatment with vinblastine.
Sersa G; Krzic M; Sentjurc M; Ivanusa T; Beravs K; Cemazar M; Auersperg M; Swartz HM
Cancer Res; 2001 May; 61(10):4266-71. PubMed ID: 11358854
[TBL] [Abstract][Full Text] [Related]
40. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
Beck WT; Cirtain MC; Look AT; Ashmun RA
Cancer Res; 1986 Feb; 46(2):778-84. PubMed ID: 3455678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
